Jason T. Christiansen
Paul Hastings LLP
Log In

General

Experience7 yrs
Elite Ratings
--
Practice Areas
Biotech (24 cases)
Chemical Biotech (2 cases)
Comp. Arch. and Software (1 case)
Law Firms
Paul Hastings LLP
jasonchristiansen@paulhastings.com
paulhastings.com

Ratings

Experience
Grade
Trend
DCT
L2
C
PTAB
--
--
--
CAFC
--
--
--

Cases

Case #
Court
Caption
Filed
Represent
1:16-CV-01045
D. DE
Forest Laboratories LLC v. Apotex Corp11/10/16
Patent Owner (W)
: Adamas Pharmaceuticals Inc;Allergan USA Inc;Forest Laboratories Holdings Ltd;Forest Laboratories LLC
1:16-CV-00375
D. DE
Forest Laboratories LLC v. Accord Healthcare Inc05/20/16
Patent Owner (W)
: Adamas Pharmaceuticals Inc;Allergan USA Inc;Forest Laboratories Holdings Ltd;Forest Laboratories LLC
1:15-CV-00966
D. DE
Forest Laboratories LLC v. Amerigen Pharma Inc10/23/15
Patent Owner (W)
: Adamas Pharmaceuticals Inc;Allergan USA Inc;Forest Laboratories Holdings Ltd;Forest Laboratories LLC
1:15-CV-07461
D. NJ
Boehringer Ingelheim Pharma GmbH & Co KG v. Sandoz Inc10/13/15
Patent Owner
: Boehringer Ingelheim Intl GmbH;Boehringer Ingelheim Pharmaceuticals Inc;Boehringer-Ingelheim Pharma GmbH
1:15-CV-00756
D. DE
Forest Laboratories LLC v. Amneal Pharma LLC08/27/15
Patent Owner (W)
: Adamas Pharmaceuticals Inc;Allergan USA Inc;Forest Laboratories Holdings Ltd;Forest Laboratories LLC
1:15-CV-00454
D. DE
Teijin Ltd v. Macleods Pharma Ltd06/04/15
Patent Owner
: Teijin Ltd;Teijin Pharma Ltd
2:15-CV-00280
D. NJ
Sumitomo Dainippon Pharma Co Ltd v. Emcure Pharma Ltd01/14/15
Patent Owner (W)
: Sumitomo Dainippon Pharma Co Ltd;Sunovion Pharmaceuticals Inc
1:14-CV-01370
D. DE
Teijin Ltd v. Unimark Remedies Ltd11/04/14
Patent Owner
: Teijin Ltd
1:14-CV-00146
N.D. WV
Boehringer Ingelheim Pharma GmbH & Co KG v. Mylan Pharma Inc08/29/14
Patent Owner
: Boehringer Ingelheim Intl GmbH;Boehringer Ingelheim Pharmaceuticals Inc;Boehringer-Ingelheim Pharma GmbH
1:14-CV-04727
D. NJ
Boehringer Ingelheim Pharma GmbH & Co KG v. Mylan Pharma Inc07/30/14
Patent Owner
: Boehringer Ingelheim Intl GmbH;Boehringer Ingelheim Pharmaceuticals Inc;Boehringer-Ingelheim Pharma GmbH

Ratings Trends

Practice Areas